The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, C. C.
Right arrow Articles by Wagtmann, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, C. C.
Right arrow Articles by Wagtmann, N.
The Journal of Immunology, 1998, 161: 571-577.
Copyright © 1998 by The American Association of Immunologists

Direct Binding and Functional Transfer of NK Cell Inhibitory Receptors Reveal Novel Patterns of HLA-C Allotype Recognition1

Christine C. Winter*, Jenny E. Gumperz2,{dagger}, Peter Parham{dagger}, Eric O. Long3,* and Nicolai Wagtmann4,*

* Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; and {dagger} Departments of Structural Biology and Microbiology and Immunology, Stanford University, Stanford, CA 94305

Cytotoxicity of human NK cells is under negative control of killer cell Ig-like receptors (KIR) specific for HLA class I. To determine the specificity of five KIR containing two Ig domains (KIR2D), direct binding of soluble recombinant KIR2D to a panel of HLA class I transfectants was assayed. One soluble KIR2D, derived from an inhibitory receptor with a long cytoplasmic tail (KIR2DL1), bound to HLA-C allotypes containing asparagine 77 and lysine 80 in the heavy chain, as expected, since these allotypes inhibit lysis by NK cells expressing KIR2DL1. Surprisingly, another KIR2D (KIR2DL2), which inhibits NK lysis of cells expressing HLA-C molecules with serine 77 and asparagine 80, bound to HLA-C allotypes carrying either amino acid motif. Expression of the KIR2DL receptors in NK cells using recombinant vaccinia viruses confirmed these patterns of recognition, and identified KIR2DL3 as another KIR reacting with both groups of HLA-C allotypes. Mutagenesis of amino acid 44 in KIR2DL1 and KIR2DL2 suggested this residue controls the affinity of KIR for the 77/80 motif of HLA-C molecules. Two other soluble KIR2D, derived from noninhibitory receptors with short cytoplasmic tails (KIR2DS), did not bind to any of the HLA class I allotypes tested. One of these receptors (KIR2DS2) is closely related in sequence to KIR2DL2. Substitution of tyrosine 45 with the phenylalanine conserved in other KIR was sufficient to permit specific binding of KIR2DS2 to HLA-C. These results show that KIR2DL receptors are specific for HLA-C, but that recognition of HLA-C allotypes appears more permissive than indicated by previous functional experiments.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. K. Moesta, L. Abi-Rached, P. J. Norman, and P. Parham
Chimpanzees Use More Varied Receptors and Ligands Than Humans for Inhibitory Killer Cell Ig-Like Receptor Recognition of the MHC-C1 and MHC-C2 Epitopes
J. Immunol., March 15, 2009; 182(6): 3628 - 3637.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. C. Whittaker, D. N. Burshtyn, S. J. Orr, L. Quigley, D. L. Hodge, V. Pascal, W. Zhang, and D. W. McVicar
Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire
Blood, October 1, 2008; 112(7): 2869 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Sharkey, L. Gardner, S. Hiby, L. Farrell, R. Apps, L. Masters, J. Goodridge, L. Lathbury, C. A. Stewart, S. Verma, et al.
Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age
J. Immunol., July 1, 2008; 181(1): 39 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
B. Foley, D. De Santis, L. Lathbury, F. Christiansen, and C. Witt
KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals
Int. Immunol., April 1, 2008; 20(4): 555 - 563.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. K. Moesta, P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham
Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3
J. Immunol., March 15, 2008; 180(6): 3969 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. J. Lavender, H. H. Chau, and K. P. Kane
Distinctive Interactions at Multiple Site 2 Subsites by Allele-Specific Rat and Mouse Ly49 Determine Functional Binding and Class I MHC Specificity
J. Immunol., November 15, 2007; 179(10): 6856 - 6866.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
J. Immunol., July 15, 2007; 179(2): 854 - 868.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. A. Guethlein, A. M. Older Aguilar, L. Abi-Rached, and P. Parham
Evolution of Killer Cell Ig-Like Receptor (KIR) Genes: Definition of an Orangutan KIR Haplotype Reveals Expansion of Lineage III KIR Associated with the Emergence of MHC-C
J. Immunol., July 1, 2007; 179(1): 491 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Raja Gabaglia, Y. Diaz de Durana, F. L. Graham, J. Gauldie, E. E. Sercarz, and T. A. Braciak
Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell-Mediated Killing of MHC Class I-Negative LNCaP Prostate Tumors
Cancer Res., March 1, 2007; 67(5): 2290 - 2297.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Jennes, S. Verheyden, C. Demanet, C. A. Adje-Toure, B. Vuylsteke, J. N. Nkengasong, and L. Kestens
Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands
J. Immunol., November 15, 2006; 177(10): 6588 - 6592.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Trichet, C. Benezech, C. Dousset, M.-C. Gesnel, M. Bonneville, and R. Breathnach
Complex Interplay of Activating and Inhibitory Signals Received by V{gamma}9V{delta}2 T Cells Revealed by Target Cell beta2-Microglobulin Knockdown
J. Immunol., November 1, 2006; 177(9): 6129 - 6136.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. J. VandenBussche, S. Dakshanamurthy, P. E. Posch, and C. K. Hurley
A Single Polymorphism Disrupts the Killer Ig-Like Receptor 2DL2/2DL3 D1 Domain
J. Immunol., October 15, 2006; 177(8): 5347 - 5357.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. P. Wittman, D. Woodburn, T. Nguyen, F. A. Neethling, S. Wright, and J. A. Weidanz
Antibody Targeting to a Class I MHC-Peptide Epitope Promotes Tumor Cell Death
J. Immunol., September 15, 2006; 177(6): 4187 - 4195.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Yawata, N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
J. Exp. Med., March 20, 2006; 203(3): 633 - 645.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Cook, D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation
Blood, February 1, 2006; 107(3): 1230 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Butsch Kovacic, M. Martin, X. Gao, T. Fuksenko, C.-J. Chen, Y.-J. Cheng, J.-Y. Chen, R. Apple, A. Hildesheim, and M. Carrington
Variation of the Killer Cell Immunoglobulin-Like Receptors and HLA-C Genes in Nasopharyngeal Carcinoma
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2673 - 2677.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. E. Kirwan and D. N. Burshtyn
Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1)
J. Immunol., October 15, 2005; 175(8): 5006 - 5015.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. A. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F. A. Arosa, et al.
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors
PNAS, September 13, 2005; 102(37): 13224 - 13229.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
A. P. Williams, A. R. Bateman, and S. I. Khakoo
HANGING IN THE BALANCE: KIR and Their Role in Disease
Mol. Interv., August 1, 2005; 5(4): 226 - 240.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
L. Abi-Rached and P. Parham
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues
J. Exp. Med., April 18, 2005; 201(8): 1319 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Rajagopalan and E. O. Long
Understanding how combinations of HLA and KIR genes influence disease
J. Exp. Med., April 4, 2005; 201(7): 1025 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Carrington, S. Wang, M. P. Martin, X. Gao, M. Schiffman, J. Cheng, R. Herrero, A. C. Rodriguez, R. Kurman, R. Mortel, et al.
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
J. Exp. Med., April 4, 2005; 201(7): 1069 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Draghi, N. Yawata, M. Gleimer, M. Yawata, N. M. Valiante, and P. Parham
Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I
Blood, March 1, 2005; 105(5): 2028 - 2035.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. E. Hiby, J. J. Walker, K. M. O'Shaughnessy, C. W.G. Redman, M. Carrington, J. Trowsdale, and A. Moffett
Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success
J. Exp. Med., October 18, 2004; 200(8): 957 - 965.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Parham
NK Cells and Trophoblasts: Partners in Pregnancy
J. Exp. Med., October 18, 2004; 200(8): 951 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Vitale, S. Carlomagno, M. Falco, D. Pende, E. Romeo, P. Rivera, M. D. Chiesa, D. Mavilio, and A. Moretta
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2
Int. Immunol., October 1, 2004; 16(10): 1459 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. I. Khakoo, C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al.
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Science, August 6, 2004; 305(5685): 872 - 874.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Katz, R. Gazit, T. I. Arnon, T. Gonen-Gross, G. Tarcic, G. Markel, R. Gruda, H. Achdout, O. Drize, S. Merims, et al.
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
J. Immunol., August 1, 2004; 173(3): 1819 - 1825.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Igarashi, J. Wynberg, R. Srinivasan, B. Becknell, J. P. McCoy Jr, Y. Takahashi, D. A. Suffredini, W. M. Linehan, M. A. Caligiuri, and R. W. Childs
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells
Blood, July 1, 2004; 104(1): 170 - 177.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. P. Goodridge, C. S. Witt, F. T. Christiansen, and H. S. Warren
KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells
J. Immunol., August 15, 2003; 171(4): 1768 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
X. Saulquin, L. N. Gastinel, and E. Vivier
Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)
J. Exp. Med., April 7, 2003; 197(7): 933 - 938.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. I. Khakoo, R. Geller, S. Shin, J. A. Jenkins, and P. Parham
The D0 Domain of KIR3D Acts as a Major Histocompatibility Complex Class I Binding Enhancer
J. Exp. Med., October 7, 2002; 196(7): 911 - 921.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. M. Vyas, K. M. Mehta, M. Morgan, H. Maniar, L. Butros, S. Jung, J. K. Burkhardt, and B. Dupont
Spatial Organization of Signal Transduction Molecules in the NK Cell Immune Synapses During MHC Class I-Regulated Noncytolytic and Cytolytic Interactions
J. Immunol., October 15, 2001; 167(8): 4358 - 4367.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. S. Warren, A. J. Campbell, J. C. Waldron, and L. L. Lanier
Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors
Int. Immunol., August 1, 2001; 13(8): 1043 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Katz, G. Markel, S.'a. Mizrahi, T. I. Arnon, and O. Mandelboim
Recognition of HLA-Cw4 but Not HLA-Cw6 by the NK Cell Receptor Killer Cell Ig-Like Receptor Two-Domain Short Tail Number 4
J. Immunol., June 15, 2001; 166(12): 7260 - 7267.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J.-H. Yen, B. E. Moore, T. Nakajima, D. Scholl, D. J. Schaid, C. M. Weyand, and J. J. Goronzy
Major Histocompatibility Complex Class I-recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis
J. Exp. Med., May 14, 2001; 193(10): 1159 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Seiffert, P. Brossart, C. Cant, M. Cella, M. Colonna, W. Brugger, L. Kanz, A. Ullrich, and H.-J. Buhring
Signal-regulatory protein {alpha} (SIRP{alpha}) but not SIRP{beta} is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38{-} hematopoietic cells
Blood, May 1, 2001; 97(9): 2741 - 2749.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. L. Hershberger, R. Shyam, A. Miura, and N. L. Letvin
Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys
J. Immunol., April 1, 2001; 166(7): 4380 - 4390.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Valés-Gómez, R. A. Erskine, M. P. Deacon, J. L. Strominger, and H. T. Reyburn
The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins
PNAS, February 1, 2001; (2001) 41618298.
[Abstract] [Full Text]

Home page
 JEMHome page
R. Rajalingam, M. Hong, E. J. Adams, B. P. Shum, L. A. Guethlein, and P. Parham
Short KIR Haplotypes in Pygmy Chimpanzee (Bonobo) Resemble the Conserved Framework of Diverse Human KIR Haplotypes
J. Exp. Med., January 2, 2001; 193(1): 135 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. H. Chung, K. Natarajan, L. F. Boyd, J. Tormo, R. A. Mariuzza, W. M. Yokoyama, and D. H. Margulies
Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells
J. Immunol., December 15, 2000; 165(12): 6922 - 6932.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. C. Nakamura, S. Hayashi, E. C. Niemi, J. C. Ryan, and W. E. Seaman
Activating Ly-49D and Inhibitory Ly-49A Natural Killer Cell Receptors Demonstrate Distinct Requirements for Interaction with H2-Dd
J. Exp. Med., August 8, 2000; 192(3): 447 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. M. Davis, I. Chiu, M. Fassett, G. B. Cohen, O. Mandelboim, and J. L. Strominger
The human natural killer cell immune synapse
PNAS, December 21, 1999; 96(26): 15062 - 15067.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Ortaldo, R. Winkler-Pickett, J. Willette-Brown, R. L. Wange, S. K. Anderson, G. J. Palumbo, L. H. Mason, and D. W. McVicar
Structure/Function Relationship of Activating Ly-49D and Inhibitory Ly-49G2 NK Receptors ,2
J. Immunol., November 15, 1999; 163(10): 5269 - 5277.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Maenaka, T. Juji, T. Nakayama, J. R. Wyer, G. F. Gao, T. Maenaka, N. R. Zaccai, A. Kikuchi, T. Yabe, K. Tokunaga, et al.
Killer Cell Immunoglobulin Receptors and T Cell Receptors Bind Peptide-Major Histocompatibility Complex Class I with Distinct Thermodynamic and Kinetic Properties
J. Biol. Chem., October 1, 1999; 274(40): 28329 - 28334.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Q. R. Fan and D. C. Wiley
Structure of Human Histocompatibility Leukocyte Antigen (HLA)-Cw4, a Ligand for the KIR2D Natural Killer Cell Inhibitory Receptor
J. Exp. Med., July 5, 1999; 190(1): 113 - 124.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. A. Snyder, A. G. Brooks, and P. D. Sun
Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2
PNAS, March 30, 1999; 96(7): 3864 - 3869.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Vales-Gomez, H. T. Reyburn, R. A. Erskine, and J. Strominger
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
PNAS, November 24, 1998; 95(24): 14326 - 14331.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Vales-Gomez, R. A. Erskine, M. P. Deacon, J. L. Strominger, and H. T. Reyburn
The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins
PNAS, February 13, 2001; 98(4): 1734 - 1739.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.